This Insight is part of your subscription to Signify Premium Insights – Medical Imaging. This content is only available to individuals with an active account for this paid-for service and is the copyright of Signify Research. Content cannot be shared or distributed to non-subscribers or other third parties without express written consent from Signify Research. To view other recent Premium Insights that are part of the service please click here.
Co-written by Amy Thompson
Although the recent annual meeting of SIIM, the Society for Imaging Informatics in Medicine show is much smaller than many of the other events on the medical imaging calendar, its focus on imaging informatics and the emphasis on business-to-business relationships means that it is still an influential event and a good bellwether of the trends in the medical imaging IT market. As such, while there was only a limited number of product announcements, the debate was stimulating. This was particularly true given that some innovative smaller vendors, which risk being crowded out at larger shows, were able to enjoy the limelight.
Continue Don’t Counter
Despite its different composition, however, the trends witnessed at the show were very much a continuation of those seen at other recent events. Such was the case for cloud technologies, for example. Vendors were keen to promote their solutions and marketing boasting of cloud capability was ubiquitous. Despite this promotion, reluctance around cloud technology remains, with providers hesitant to commit themselves completely to a fully cloud-based platform deployment. This reticence is largely a result of providers’ scepticism that cloud solutions can match the performance of on-premise data centres, especially when evaluating performance of core diagnostic tools such as the PACS which plays a critical role in patient care. After all, any slight delay in accessing an image or report, even by a few seconds, for example, is not something a provider is willing to accept when it could impact patient care.
While providers are yet to be fully convinced of the merits of a transition to cloud, vendors also still have some work to do. Although almost all vendors offer some cloud capability, and some vendors can offer some cloud-based enterprise imaging, no vendor is yet ready to offer a complete cloud-based enterprise imaging platform at scale. While interest in cloud continues to grow, these challenges mean that providers will continue to favour hybrid cloud solutions as opposed to fully hosted public cloud. This approach could cause a provider to miss some of the more sophisticated opportunities offered by full cloud deployments, though in the near term retaining some core components, such as AV or the core diagnostic PACS on premise represents a sensible compromise. Further, in many cases it will allow providers to enjoy the benefits of the evolution towards a SaaS-based business model, without risking any detriment to performance that they fear from a full cloud deployment.
Cybersafety in the Cloud
Despite these reservations however, there are some reasons motivating providers to adopt cloud solutions. Among the most prominent of those at SIIM, especially compared to previous years, was cybersecurity. Although cybersecurity has been a concern for a number of years, the growth in the numbers of ransomware attacks has helped mean that cybersecurity has become one of the main catalysts driving the transition to cloud, especially at larger organisations.
Progress is slow, however. This is particularly true as the transition to cloud isn’t occurring in isolation, with the development coinciding with the broader adoption of enterprise imaging strategies. As such, vendors and providers aren’t merely focused on the technical challenges, they are also determining how departments other than radiology, such as cardiology and pathology will sit in the cloud. Digital pathology images, for example, offer unique challenges compared to radiological images, in part due to their sheer size and differing workflow. These are challenges that will be addressed, but at present, despite some vendors’ fanfare, adoption of cloud technology has been fastest at specific customer segments, such as smaller outpatient sites (looking to remove IT administration burden), and academic sites (leveraging cloud for research). The bulk of the market has still not made the jump, and in many cases, won’t do for some time.
Pathologically Minded
Another of the major technological changes that vendors and providers were discussing at the show was digital pathology. There has been more interest in digital pathology since the Covid-19 pandemic, which highlighted the possibilities of digitisation for a number of clinical areas and hospital departments. In the US this is being reflected by the easing of FDA rules on primary diagnostic use of digital pathology, which is offering the opportunity for imaging IT vendors to enter the market and create interoperability between two departments and their specialists.
While there are some imaging IT vendors that do already offer capability in digital pathology, the fact the topic was being very visibly discussed at a traditionally radiology-focused show, shows that it is becoming a more mainstream opportunity. The fruits of vendor investment in this sector will take time to be realised however. Significant questions need to be answered such as whether a specialist viewer is required, or if it is preferable to be able to view pathology images in the radiology viewer, and whether radiologists need access to slides or if access to the report is sufficient, must all be determined. Notably, some imaging IT vendors are circumventing this learning curve by partnering up with digital pathology specialists, with traction already evident in Europe. The same is expected in North America in the near-term future.
Exchange of Information
The technology to underpin image exchange is very attainable for a large imaging IT vendor, but whether it is worth attaining is still unknown, with vendors keen to understand the market opportunity for such solutions. This is in part because, at least in private markets, it represents something of a double-edged sword, with providers interested in the ability to share images between their own sites (intra-network exchange), and the ability to use the technology as a differentiator to entice patients in. However, making images easier to share also means patients will find it easier to leave one provider network (inter-network exchange), a loss of business that hospitals will not wish to facilitate.
Despite these questions, from a market perspective the additional interest from providers does make sense. Spurred on by the need for digitisation during the Covid-19 pandemic, image exchange is becoming a dedicated budget item for providers, giving imaging IT vendors more of a reason to target the segment for upsell opportunities. However, particularly in comparison to the core imaging IT platform, it is still a very small market. Moreover, it is also likely to be a market that will increasingly become integrated into enterprise imaging platform competency as providers continue to consolidate contracts and streamline technology.
Putting Words to Good Use
Such discussions surrounding upcoming technological shifts will have been useful for vendors. The show highlighted that vendors must be able to demonstrate considered, deliverable strategies for several technologies instrumental in the development of the imaging IT market. Providers might not be looking to make the switch to new technologies and systems today, but they need to know that when it comes to cloud capability, AI integration platforms and enterprise imaging and interoperability tools, their chosen vendor must be ready when they are.
About Signify Premium Insights
This Insight is part of your subscription to Signify Premium Insights – Medical Imaging. This content is only available to individuals with an active account for this paid-for service and is the copyright of Signify Research. Content cannot be shared or distributed to non-subscribers or other third parties without express written consent from Signify Research. To view other recent Premium Insights that are part of the service please click here